Emerald Health Completes Northern Vine Acquisition

Emerald Health Therapeutics (TSXV:EMH) completed its total acquisition of Northern Vine Canada from Abattis Bioceuticals (CSE:ATT) for C$2 million in cash and 1,093,938 common shares of the company. As quoted in the press release: Northern Vine is a Licensed Dealer (LD) under the provisions of the Canadian Controlled Drugs and Substances Act. The dealer license allows Emerald to participate in the growing market for cannabis analytical testing, which Emerald expects to grow in conjunction with increasing cannabis production volumes in Canada. Northern Vine will operate independently of Emerald and is committed to serving all clients, including Licensed Producers and patient-growers. Legalization of cannabis for medical purposes and the upcoming legalization of cannabis for recreational purposes is expected to drive demand for analytical testing services to assess potency and concentration of toxic materials. This acquisition also allows Emerald to leverage Northern Vine’s dealer license to advance research plans to develop cannabis formulations supporting … Continue reading

Kalytera Therapeutics, Inc. Announces Exercise of Over-Allotment Option

Kalytera Therapeutics, Inc. (TSXV:KALY) (OTCQB:KALTF) (the “Company” or “Kalytera”) is pleased to announce that in connection with its previously announced public offering (the “Offering”) of units of the Company (“Units”) for aggregate gross proceeds of CDN$4,297,260, Echelon Wealth Partners Inc. (“Echelon”) who acted as agent for and on behalf of the Company in connection with the Offering, has exercised its over-allotment option in full, and an additional 5,859,900 Units were issued today representing additional gross proceeds of CDN$644,589. Each Unit consists of one common share in the Company (each a “Common Share”) and one-half of one common share purchase warrant (each whole warrant, a “Warrant”).  Each Warrant entitles the holder thereof to acquire one Common Share at a price of CDN$0.155 (subject to customary adjustments for certain events) for a period of 36 months from the initial closing date of the Offering. On closing of the exercise of the over-allotment … Continue reading

INDIVA is Looking Forward to Selling Directly to Consumers

INDIVA (TSXV:NDVA) CEO Niel Marotta was featured in an article published by the London Free Press. In the article, Marotta discussed the significance of being granted a federal license for selling cannabis, which gives INDIVA the ability to sell directly to cannabis consumers instead of going through a state-run store. INDIVA will be able to send out its first orders to cannabis patients through the company’s website later this year. “We would love to do that . . . As a licenced producer, having our own store would be a natural extension. It would be a chance to showcase our products and educate consumers,” said Marotta. The article also covered INDIVA’s growing facilities. INDIVA is in the process of expanding its facilities to ensure that they have a steady supply of cannabis for the medical cannabis market. Marotta also divulged that the company is looking into establishing an outdoor growing … Continue reading

Is Constellation Brands Now a Marijuana Stock? - Fox Business

Is Constellation Brands Now a Marijuana Stock?Fox BusinessWhile this stake will allow Constellation Brands to better enter a potential growth area, it’s not quite a marijuana stock. Investors should understand that this purchase won’t have an immediate effect on the broader business. Last quarter, Canopy …The world’s biggest marijuana stock is surging after a $4 million investment from the maker of CoronaMarkets InsiderCannabis company Canopy Growth’s stock soars 28% as Corona brewer increases stakeMarketWatchCorona owner makes $4 billion bet on cannabisCNNMoney all 559 news articles Continue Reading … Continue reading

Ancient Strains Announces Two Strategic Cannabis Service Agreements

Ancient Strains Limited (“Ancient Strains” or “ASL”) is pleased to announce that it has signed two binding agreements with strategic cannabis service providers that will greatly enhance Ancient Strains’ ability to expand its international footprint and develop unique medicinal cannabis products. One is with CannOps Consulting Services Ltd. (“CannOps”) and one is indirectly through Battalion Consol Corp. (“BATC”). Under the terms of the agreement with CannOps (the “CannOps Agreement”), CannOps will, among other things, supply product from its genetic library, work with Ancient Strains to develop medicinal cannabis extract product lines and assist in marketing and distribution. Ancient Strains will use the genetics and strains to enhance its position in the international business of medicinal cannabis. Pursuant to the confidential terms of the agreement with Battalion Consol Corporation (the “BATC Agreement”), Ancient Strains will purchase BATC’s minority equity interest in a licensed analytics lab located in Canada (the “LD”). The BATC Agreement … Continue reading

Pure Global Cannabis Announces Transformational International Expansion Into Latin America

Pure Global Cannabis Inc. (TSX.V:PURE; OTC: PRCNF)  (the “Company” or “Pure Global”), a vertically-integrated, growth-oriented life sciences cannabis company, is pleased to announce that it has entered into a binding letter agreement (the “Agreement”) with Avicanna Inc. (“Avicanna”) to acquire a 60% interest in Avicanna’s Colombian subsidiary, Sativa Nativa S.A.S. (“Sativa Nativa”). In addition, Avicanna will also grant Pure Global an option to acquire an additional 15% in Sativa Nativa for an aggregate ownership of 75%.  Sativa Nativa has been issued a license for the cultivation of psychoactive cannabis and a license for the manufacture of cannabis derivatives by the Colombian Ministry of Justice and Ministry of Health. Malay Panchal, President & CEO of Pure Global, stated: “This is an exciting day for Pure Global as we make our first entry into Latin America and kickstart our international growth plans. We have found an excellent partner in Avicanna, which has done a tremendous job … Continue reading

GTEC’s Extraction Facility on Track for 2019

GTEC Holdings Ltd. (TSXV:GTEC) (OTC:GGTTF) (“GTEC” or the “Company”), is pleased to provide an update on its wholly owned subsidiary, Spectre Labs Inc. (“Spectre Labs” or “Spectre”). GTEC previously announced that it had acquired a warehouse located in Kelowna, B.C. for the purpose of submitting an application to the Office of Controlled Substances for a Dealer’s Licence. The site will be developed in a phased approach and will serve as a Good Manufacturing Practices (GMP) grade facility with extraction, formulation, compounding and export capabilities to support GTEC’s Licensed Producers and the global medical market. GTEC also intends to utilize this facility to manufacture edible products that are expected to be incorporated into Health Canada’s regulatory framework in 2019. Upon Health Canada approval of phase one, the facility will be capable of producing up to 24,500 grams of cannabis oil per day (equivalent to more than 8,500 kilograms per annum), with capacity to … Continue reading

FSD Pharma and SciCann Therapeutics Launch Clinical Research Program in Israel

FSD Pharma Inc. (“FSD Pharma”) (CSE:HUGE) (OTC:FSDDF) (FRA:0K9), announced today the launch of a clinical research collaborative program in Israel, via its strategic R&D partner, SciCann Therapeutics Inc. (“SciCann”) This comprehensive clinical research program will be executed through SciCann’s strategic alliance and collaboration agreement with Mor Research Applications Ltd. (“Mor”) – the technology transfer office and commercial arm of Clalit Healthcare Services, Israel’s largest medical insurer and healthcare provider, which operates a network of 14 full scale hospitals throughout Israel, employs over 9,000 physicians and serves the healthcare needs of over 50% of Israel’spopulation. As announced previously, FSD Pharma has secured the exclusive licensing rights for the manufacturing and distribution of SciCann’s line of proprietary, patent-pending, cannabinoid-based and indication-specific products in Canada. Under the strategic alliance agreement with Mor, FSD Pharma and SciCann will execute a series of rigorous, randomized, placebo-controlled clinical studies to demonstrate the safety and efficacy of these products, in order to bring … Continue reading

Naturally Splendid Announces Purchase Order for National Distribution Bar Line

Naturally Splendid Enterprises Ltd. (“Naturally Splendid” or “NSE” or “The Company”) (TSXV:NSP) (OTCQB:NSPDF) (Frankfurt:50N) is pleased to announce it has secured the initial Purchase Order for a National Food Retailing / Branding company for a new retail energy bar.  This bar has been custom formulated at the Company’s newly renovated bar manufacturing facility located in Pitt Meadows, British Columbia. This initial Purchase Order is in excess of $73,000 and is expected to be the first in a series of purchase orders for this client, as they expand their retail business across Canada and into the USA. The expansion of the Company’s bars-and-bites business model continues its strategy to gain market share in the healthy food sector retail markets and to add significant clients. Alan Maddox, Naturally Splendid’s Executive Vice-President of Sales, states, “With the expanded R&D and manufacturing capabilities, the Company is well positioned, as an innovator in the bar/snack sector … Continue reading

Nutritional High Congratulates Aura Health on Its Commencing Trading on the CSE

Nutritional High International Inc. (the “Company” or “Nutritional High”) (CSE: EAT, OTCQB: SPLIF, FRANKFURT: 2NU) would like to congratulate Aura Health Inc. (“Aura”) (CSE: BUZZ) for their listing approval and commencement of trading on Thursday, August, 15th under the symbol “BUZZ”. As a major shareholder in Aura, Nutritional High is pleased to see the achievement of this major corporate milestone. Aura is engaged in the acquisition and management of marijuana service businesses and currently holds minority interests in 4 medical marijuana clinics in Arizona, Nevada and Florida. Its long-term goal is to build an international network of vertically integrated businesses in the medical marijuana field. Jim Frazier, the CEO of Nutritional High, commented, “This milestone for Aura is a key aspect of their growth plan and overall corporate strategic vision. Nutritional High has no doubt that Aura will continue to enhance and provide shareholder value to their current network and future … Continue reading